Tag Archives: Press release

Enquête EpiCov : 2e phase lancée depuis le 26 octobre 2020

Afin de prolonger et d’approfondir la connaissance sur les conséquences de l’épidémie et des mesures sanitaires sur les conditions de vie et les inégalités sociales dans la population, la Direction de la recherche, des études, de l’évaluation et des statistiques (DREES) et l’Institut national de la santé et de la recherche médicale (Inserm) en collaboration avec Santé publique France, l’Insee, le CNRS, l’Ined, et l’université Paris-Saclay lancent la deuxième vague de l’enquête EpiCov.

Posted in Press releases, Public health | Tagged | Comments closed

Food Emulsifiers Increase Pathogenicity of Certain Bacteria and Risk of Intestinal Inflammation

Diet is believed to play a role in triggering intestinal inflammation that can lead to the development of certain conditions, such as Crohn’s disease. Researchers from Inserm, CNRS and Université de Paris have shown that the emulsifiers present in many processed foods could have a harmful impact on specific bacteria in the gut microbiota, leading to chronic inflammation.

Posted in Cell biology, development and evolution, Press releases, Genetics, genomics and bioinformatics, Immunology, inflammation, infectiology and microbiology | Tagged | Comments closed

Confirmation des premiers résultats de l’essai CORIMUNO-TOCI-1

Chez certains patients avec pneumonie Covid-19, un état hyperinflammatoire d’origine immunologique contribue à l’insuffisance respiratoire aigüe et au décès. La plateforme CORIMUNO-19 a été rapidement mise en place pour permettre de tester l’efficacité et la tolérance de divers médicaments immuno-modulateurs chez les patients adultes avec infection COVID-19 modérée à sévère, grâce à une série d’essais randomisés contrôlés multicentriques, qui ont débuté le 27 mars 2020.

Posted in Press releases, Immunology, inflammation, infectiology and microbiology | Tagged | Comments closed

An Immune “Signature” to Identify Diabetic Patients at Risk of Developing Severe Covid-19

Type 2 diabetes is a risk factor for the development of a severe form of Covid-19. Identifying the immune- and inflammatory markers associated with these severe forms of the disease in this patient population would enable earlier and more appropriate care.

Posted in Press releases, Circulation, metabolism, nutrition | Tagged | Comments closed

A New Therapeutic Target for Type 2 Diabetes Discovered Thanks to a Rare Disease

A new therapeutic target for type 2 diabetes has recently been identified by researchers from Inserm and Université de Strasbourg, in collaboration with several European hospitals.

Posted in Press releases, Genetics, genomics and bioinformatics, Circulation, metabolism, nutrition | Tagged | Comments closed

Premiers résultats des enquêtes de santé publique de l’Inserm sur la Covid-19 : facteurs de risque individuels et sociaux

Pour répondre aux questions de santé publique posées par l’épidémie de Covid-19, des enquêtes multidisciplinaires de grande ampleur ont été lancées à l’Inserm. Deux grandes enquêtes de santé publique : SAPRIS et EpiCoV, livrent aujourd’hui leurs premiers résultats.

Posted in Press releases, Institutional and special event, Public health | Tagged | Comments closed

Fibromyalgia, Knowledge Overview and Recommendations: An Inserm Collective Expert Review

Inserm was tasked by France’s Health Directorate with conducting a Collective Expert Review in order to take stock of the scientific knowledge on fibromyalgia in adults, and also to explore the potential existence of a similar syndrome in children and adolescents. The objective was also to recommend measures and establish research priorities in order to better understand fibromyalgia and improve patient care.

Posted in Press releases, Institutional and special event, Public health | Tagged | Comments closed

The Placenta Could Retain a Memory of Tobacco Exposure Prior to Pregnancy

A study is showing for the first time that tobacco consumption, even when stopped before pregnancy, can have an impact on the placenta. Smoking not just during but also before pregnancy leads to epigenetic modifications (DNA methylation) which could have consequences on its course.

Posted in Cell biology, development and evolution, Press releases, Genetics, genomics and bioinformatics, Public health | Tagged | Comments closed

COVID-19 Vaccines: 25,000 Volunteers Needed for Large-Scale Clinical Trials in France – Registration Now Open

Today, COVIREIVAC opens the registration process for volunteers to participate in the first large-scale clinical trials in France.

Posted in Press releases, Immunology, inflammation, infectiology and microbiology, Institutional and special event, Public health | Tagged | Comments closed

New Whooping Cough Vaccine In Development

Boîte de pétri contenant une Culture de Bordetella pertussis, l’agent causal de la coqueluche.

A research team from Inserm, Lille University, Lille University Hospital, CNRS, and the Institut Pasteur of Lille, as part of the Lille Immunity and Infection Center, is developing a new vaccine against whooping cough. En utilisant la bactérie entière mais génétiquement modifiée pour supprimer sa toxicité, les chercheurs espèrent pallier les défauts d’efficacité du vaccin actuel en induisant une réponse immunitaire durable et en bloquant la transmission bactérienne entre individus.

Posted in Press releases, Immunology, inflammation, infectiology and microbiology, Public health | Tagged | Comments closed
fermer
fermer
RSS Youtube